Compared to placebo, a vitamin C/mineral combination had no effect on reducing the prevalence of cataracts for treatment durations of up to seven years [113]
Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
Reduced carbohydrate cravings and easier satiety may indicate positive metabolic shifts
Yet, for all their benefits, they often leave one visible drawback: their impact on the skin
Obviously, cancer of any type is not something that you want to deal with